Limits...
Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure

View Article: PubMed Central - PubMed

ABSTRACT

Background: High quality clinical samples are critical for meaningful interpretation of data obtained in both basic and translational medicine. More specifically, optimized pre-analysis handling to bio-sample is crucial for avoiding biased analysis in a clinical setting. A universally applicable method for the evaluation of sample quality and pre-analysis handling is therefore in great demand.

Methods: The fingerprint pattern of low molecular weight (LMW) peptides in sera is directly associated with sample quality and handling process. Previous studies for enrichment/isolation of LMW peptides have shown that LMW peptides can be enriched by silica meso-porous material in a sensitive and high-throughput manner. Here, a peptide profile approach utilizing mesoporous silica chip-based sample preparation combined with MALDI MS analysis was used as a new platform for evaluation of bio-sample quality. Rat sera were selected as model sample and analyzed according to their LMW peptide fingerprint spectra.

Results: This novel method can complete the entire sample preparation procedure in a short period of time (<40 min), requires minimum amounts of sample (<10 µL), is of high sensitivity (LOD 10 ng/mL) as well as high reproducibility (CV% < 15%). According to the acquired LMW peptide spectra, we were able to distinguish the serum samples processed under different conditions (including different storage temperature, time, and freezing/thaw cycles) with the help of bioinformatics tools (principle composition analysis and significant difference analysis), and identify the samples that had significantly changed due to the inappropriate processing. Based on the percentage of significantly changed peaks in LMW peptide mass spectrum after handling, a judgment standard was established that can be used to evaluate the status of preservation of a biological sample. In addition, our principle study established recommendations for storage time, storage temperature and freeze/thaw conditions.

Conclusion: Our novel method for analysis of bio-samples allows for effective identification of variations in composition within samples, and provides a cost-effective tool for simple sample manipulation in a clinical setting.

No MeSH data available.


MALDI MS spectra of serums stored at different temperatures (−190, −80, −20, 4 and 25 °C) for 9 days and fresh collected serum
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC5120552&req=5

Fig3: MALDI MS spectra of serums stored at different temperatures (−190, −80, −20, 4 and 25 °C) for 9 days and fresh collected serum

Mentions: After 9 day storage, obvious changes were observed directly in the MS spectra of the serums at 25 °C (Fig. 3). A more distinct differentiation was illustrated in PCA analysis (Fig. 4). The 25 °C samples was the most distinctive group, far away from the samples stored at other temperatures. Meanwhile, the 4 °C group also showed a complete separation from the fresh samples, indicating that the 4 °C is also a destructive condition for the long-term storage. Comparatively, the MS patterns from −20, −80, and −190 °C groups are much closer or even overlapped to the fresh serum group, suggesting the key effect of freezing for the sample long-term storage. Lower temperature showed better conservation effects, as can be seen in −80 and −190 °C group, which just partially separated from the fresh group.Fig. 3


Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure
MALDI MS spectra of serums stored at different temperatures (−190, −80, −20, 4 and 25 °C) for 9 days and fresh collected serum
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC5120552&req=5

Fig3: MALDI MS spectra of serums stored at different temperatures (−190, −80, −20, 4 and 25 °C) for 9 days and fresh collected serum
Mentions: After 9 day storage, obvious changes were observed directly in the MS spectra of the serums at 25 °C (Fig. 3). A more distinct differentiation was illustrated in PCA analysis (Fig. 4). The 25 °C samples was the most distinctive group, far away from the samples stored at other temperatures. Meanwhile, the 4 °C group also showed a complete separation from the fresh samples, indicating that the 4 °C is also a destructive condition for the long-term storage. Comparatively, the MS patterns from −20, −80, and −190 °C groups are much closer or even overlapped to the fresh serum group, suggesting the key effect of freezing for the sample long-term storage. Lower temperature showed better conservation effects, as can be seen in −80 and −190 °C group, which just partially separated from the fresh group.Fig. 3

View Article: PubMed Central - PubMed

ABSTRACT

Background: High quality clinical samples are critical for meaningful interpretation of data obtained in both basic and translational medicine. More specifically, optimized pre-analysis handling to bio-sample is crucial for avoiding biased analysis in a clinical setting. A universally applicable method for the evaluation of sample quality and pre-analysis handling is therefore in great demand.

Methods: The fingerprint pattern of low molecular weight (LMW) peptides in sera is directly associated with sample quality and handling process. Previous studies for enrichment/isolation of LMW peptides have shown that LMW peptides can be enriched by silica meso-porous material in a sensitive and high-throughput manner. Here, a peptide profile approach utilizing mesoporous silica chip-based sample preparation combined with MALDI MS analysis was used as a new platform for evaluation of bio-sample quality. Rat sera were selected as model sample and analyzed according to their LMW peptide fingerprint spectra.

Results: This novel method can complete the entire sample preparation procedure in a short period of time (<40 min), requires minimum amounts of sample (<10 µL), is of high sensitivity (LOD 10 ng/mL) as well as high reproducibility (CV% < 15%). According to the acquired LMW peptide spectra, we were able to distinguish the serum samples processed under different conditions (including different storage temperature, time, and freezing/thaw cycles) with the help of bioinformatics tools (principle composition analysis and significant difference analysis), and identify the samples that had significantly changed due to the inappropriate processing. Based on the percentage of significantly changed peaks in LMW peptide mass spectrum after handling, a judgment standard was established that can be used to evaluate the status of preservation of a biological sample. In addition, our principle study established recommendations for storage time, storage temperature and freeze/thaw conditions.

Conclusion: Our novel method for analysis of bio-samples allows for effective identification of variations in composition within samples, and provides a cost-effective tool for simple sample manipulation in a clinical setting.

No MeSH data available.